Literature DB >> 6438689

Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach.

R J Branconnier, G F Oxenkrug, I McIntyre, N Pomara, N E Harto, S Gershon.   

Abstract

Dexamethasone (DEX, 0.5 mg orally at 11 PM) challenge was used for the assessment of hypothalamic-pituitary-adrenal (HPA) activity in 20 normal volunteers. Age and pre-DEX serum cortisol levels were theè evaluated as predictors of postDEX serum cortisol levels using step-wise multiple regression analysis. Both age and preDEX serum cortisol levels were significant predictors of postDEX serum cortisol levels. It is suggested that the adjustment for age and preDEX serum cortisol level could be useful for the interpretation of abnormal postDEX levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438689     DOI: 10.1007/bf00427458

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  The dexamethasone suppression test in depressive illness: clinical correlates.

Authors:  G M Asnis; U Halbreich; R S Nathan; L Ostrow; H Novacenko; J Endicott; E J Sachar
Journal:  Psychoneuroendocrinology       Date:  1982       Impact factor: 4.905

2.  Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

Authors:  B J Carroll; G C Curtis; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1976-09

3.  Cortisol secretion in relation to age in major depression.

Authors:  G M Asnis; E J Sachar; U Halbreich; R S Nathan; H Novacenko; L C Ostrow
Journal:  Psychosom Med       Date:  1981-06       Impact factor: 4.312

4.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

Authors:  B J Carroll; M Feinberg; J F Greden; J Tarika; A A Albala; R F Haskett; N M James; Z Kronfol; N Lohr; M Steiner; J P de Vigne; E Young
Journal:  Arch Gen Psychiatry       Date:  1981-01

5.  Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.

Authors:  P E Stokes; P M Stoll; S H Koslow; J W Maas; J M Davis; A C Swann; E Robins
Journal:  Arch Gen Psychiatry       Date:  1984-03

6.  Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?

Authors:  W A Brown; C B Qualls
Journal:  Psychiatry Res       Date:  1981-04       Impact factor: 3.222

7.  Major depressive episode and low dose dexamethasone suppression test.

Authors:  M Sarai; N Taniguchi; T Kagomoto; H Kameda; T Uema; Y Hishikawa
Journal:  Folia Psychiatr Neurol Jpn       Date:  1982

8.  Resistance to inhibiting effect of dexamethasone in patients with endogenous depression.

Authors:  J L Nuller; M N Ostroumova
Journal:  Acta Psychiatr Scand       Date:  1980-02       Impact factor: 6.392

9.  The dexamethasone suppression test in an elderly population.

Authors:  M F Tourigny-Rivard; M Raskind; D Rivard
Journal:  Biol Psychiatry       Date:  1981-12       Impact factor: 13.382

  9 in total
  4 in total

1.  Prediction of cortisol response to dexamethasone from age and basal cortisol in normal volunteers: a negative study.

Authors:  M Ansseau; R von Frenckell; C Simon; J Sulon; E Demey-Ponsart; G Franck
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Age-related changes in hypothalamic-pituitary-adrenal axis activity in patients with manifest arterial disease.

Authors:  Arnoud J G Knoops; Yolanda van der Graaf; Willem P Th M Mali; Mirjam I Geerlings
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

Review 3.  Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

Authors:  J Lindholm
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

4.  Transgenerational effects of prenatal synthetic glucocorticoids on hypothalamic-pituitary-adrenal function.

Authors:  Majid Iqbal; Vasilis G Moisiadis; Alisa Kostaki; Stephen G Matthews
Journal:  Endocrinology       Date:  2012-05-07       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.